From: Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk
Total (n = 43) | HGSw (n = 31) | Non-HGSw (n = 12) | |
---|---|---|---|
Gender(M/F) | (40/3) | 28/3 | 12/0 |
Age | 72.3 ± 9.2 | 75.2 ± 7.3 | 65.1 ± 9.8 |
Smoking (+/−/ex) n(%) | 9/3/31 (20.9/7/72.1) | 3/3/25 (9.7/9.7/80.6) | 6/0/6 (50/0/50)* |
Hypertension n(%) | 18 (41.9) | 14 (45.2) | 4 (33.3) |
CVA n(%) | 1 (2.3) | 1 (3.2) | 0 (0) |
DM n(%) | 8 (18.6) | 5 (16.1) | 3 (25.0) |
Heart disease n(%) | 10 (23.3) | 7 (22.6) | 3 (25.0) |
CAD | 8 (18.6) | 5 (16.1) | 3 (25.0) |
VHD | 2 (4.6) | 2 (6.4) | 0 (0) |
CKD n(%) | 1 (2.3) | 1 (3.2) | 0 (0) |
Cancer n(%) | 2 (4.7) | 2 (6.5) | 0 (0) |
Exacerbation in previous year | 0.67 ± 1.36 | 0.74 ± 1.53 | 0.50 ± 0.80 |
BMI (kg/m2) | 23.3 ± 4.3 | 22.3 ± 4.2 | 25.8 ± 3.6* |
SMI (kg/m2) | 17.2 ± 2.0 | 16.5 ± 1.8 | 18.8 ± 1.3* |
HGS (kg) | 25.3 ± 6.5 | 22.1 ± 4.1 | 33.7 ± 3.1* |
Hospitalization duration (day) | 8.2 ± 5.2 | 8.84 ± 5.8 | 6.5 ± 2.4 |